Lipid peroxidation products as oxidative stress biomarkers

BioFactors

Volumn 34, Issue 2, 2008, Pages 171-180

  Niki, Etsuo ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Biomarker; HODE; Isoprostane; Lipid peroxidation; Oxidative stress; Oxysterol

Indexed keywords

2 HEXENAL; ACROLEIN; ALPHA CHLOROHYDRIN; ARACHIDONIC ACID; BIOLOGICAL MARKER; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLESTEROL DERIVATIVE; CROTONALDEHYDE; CYTOCHROME P450 3A4; DOCOSAHEXAENOIC ACID; EPOXIDE; GLUTATHIONE PEROXIDASE; GLYOXAL; HYDROXYOCTADECADIENOIC ACID; ISOPROSTANE; LINOLEIC ACID; LIPID HYDROPEROXIDE; MALONALDEHYDE; METHYLGLYOXAL; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXYGENASE; OXYSTEROL; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ASSOCIATION; BLOOD LEVEL; ENZYME ACTIVITY; ENZYME SPECIFICITY; HUMAN; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW;

ANIMALS; BIOLOGICAL MARKERS; HUMANS; ISOPROSTANES; LIPID PEROXIDATION; OXIDATIVE STRESS;

EID: 69449108348     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520340208     Document Type: Review

References (66)

1. J. Alary, F. Bravais, J.P. Cravedi, L. Debrauwer, D. Rao and G. Bories, Mercapturic acid conjugates as urinary end metabolites of the lipid Peroxidation product 4-hydroxy-2-nonenal in the rat, Chem Res Toxicol 8 (1995), 34-39.
2. P.R.S. Baker, F.J. Schopfer, S. Sweeney and B.A. Freeman, Red cell membrane and plasma linoleic acid nitration products: Synthesis, clinical identification and quantitation, Proc Natl Acad Sci USA 101 (2004), 11577-11582.
3. I. Björkhem, Rediscovery of cerebrosterol, Lipids 42 (2007), 5-14.
4. I. Bjorkhem and U. Diczfalusy, Oxysterols, Friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol 22 (2002), 734-742.
5. A.J. Brown and W. Jessup, Oxysterols and atherosclerosis, Atherosclerosis 142 (1999), 1-28.
6. Z.H. Chen, Y. Yoshida, Y. Saito, A. Sekine, N. Noguchi and E. Niki, Induction of adaptive response and enhancement of PC12 cell tolerance by 7-hydroxycholesterol and 15-deoxy-delta812,14)-prostaglandin J2 through up-regulation of cellular glutathione via different mechanisms, J Biol Chem 281 (2006), 14440-14445.
7. M.Y. Chou, K. Hartvigsen, L.F. Hansen, L. Fogelstrand, P.X. Shaw, A. Boullier, C.J. Binder and J.L.Witztum, Oxidationspecific epitopes are important tagets of innate immunity, J Intern Med 263 (2008), 479-488.
8. I. Dalle-Donne, R. Rossi, R. Colombo, D. Giustarini and A. Milzani, Biomarkers of oxidative damage in human disease, Clin Chem 52 (2006), 601-623.
9. M.J. Davies, The oxidative environment and protein damage, Biochim Biophys Acta 1703 (2005), 93-109.
10. M. Dizdaroglu, P. Jaruga, M. Birincioglu and H. Rodriguez, Free radical-induced damage to DNA: mechanisms and measurement, Free Radic Biol Med 32 (2002), 1102-1115. (Pubitemid 34603348)
11. Y. Dotan, D. Lichtenberg and I. Pinchuk, Lipid Peroxidation cannot be used as a universal criterion of oxidative stress, Prog Lipid Res 43 (2004), 200-227. (Pubitemid 38299193)
12. J.P. Fabisiak, Y.Y. Tyurina, V.A. Tyurina and V.E. Kagan, Quantification of selective phosphatidylserine oxidation during apoptosis, Methods Mol Biol 291 (2005), 449-456.
13. B.A. Freeman, P.R.S. Baker, F.J. Schopfer, S.R. Woodcock, A. Napolitano and M. d'Ischia, Nitro-fatty acid formation and signaling, J Biol Chem 283 (2008), 15515-15519.
14. C. Gniwotta, J.D. Morrow, L.J. Roberts 2nd and H. Kuhn, Prostaglandin F2-like compounds, F2-isoprostanes, are present in increased amounts in human atherosclerotic lesions, Arterioscler Thromb Vasc Biol 17 (1997), 3236-3241.
15. J.M.C. Gutteridge, Lipid peroxidation and antioxidnats as biomarkers of tissue damage, Clin Chem 41 (1995), 1819-1828.
16. J.W. Heinecke, Oxidized amino acids: Culprits in human atherosclerosis and indicators of oxidative stress, Free Radic Biol Med 32 (2002), 1090-1101.
17. H. Itabe and T. Takano, Oxidized low density lipoprotein: the occurrence and metabolism in circulation and in foam cells, J Atheroscler Thromb 7 (2000), 123-131.
18. L. Iuliano, F. Micheletta, S. Natoli, S.G. Corrandini, M. Iappelli, W. Elisei, L. Giovannelli, F. Violi and U. Diczfalusy, Measurement of oxysterols and a-tocopherol in plasma and tissue samples as indices of oxidant stress status, Anal Biochem 312 (2003), 217-223.
19. H. Kasai and S. Nishimura, Hydroxylation of deoxyguanosine at the C-8 position by polyphenols and aminophenols in the presence of hydrogen peroxide and ferric ion, Gann 75 (1984), 565-566.
20. Y. Kato, Y. Mori, Y. Makino, Y. Morimitsu, S. Hiroi, T. Ishikawa and T. Osawa, Formation of Ne-8hexanoyl) lysine in protein exposed to lipid hydroperoxide, J Biol Chem 274 (1999), 20406-20414.
21. R. Katz, Biomarkers and surrogate markers: An FDA perspective, J Am Soc Exper Neuro Therap 1 (2004), 189-195.
22. Y. Kawai, H. Fujii, Y. Kato, M. Kodama, M. Naito, K. Uchida and T. Osawa, Esterifed lipid hydroperoxide-derived modification of protein: formation of a carboxyalkylamide-type lysine adduct in human atherosclerotic lesions, Biochem Biophys Res Commun 313 (2004), 271-276.
23. M. Kemp, Y.M. Go and D.P. Jones, Nonequilibrium thermodynamics of thiol/disulfide redox systems: perspectives on redox systems biology, Free Radic Biol Med 44 (2008), 921-937.
24. S. Kitano, Y. Yoshida, K. Kawano, N. Hibi and E. Niki, Oxidative stress of human LDL isolated by anion-exchange HPLC by tHODE and 8-iso-prostaglandin F(2a), Anal Chim Acta 585 (2007), 86-93.
25. T. Kriska, V.V. Levchenko, F. Chu, R.S. Esworthy and A.W. Girotti, Novel enrichment of tumor cell transfectants expressing high levels of type 4 gultathione peroxidase using 7a-hydroperoxycholestero as a selection agent, Free Radic Biol Med 45 (2008), 700-707.
26. H. Larsson, Y. Bottinger, L. Iuliano and U. Diczfalusy, In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress, Free Radic Biol Med 43 (2007), 695-701.
27. C.J. Lee, S. H. Huang, A.M. Jenner and B. Halliwell, Measurement of F2-isoprostanes, hydroxyeicosatetraenoic products, and oxysterols from a single sample, Free Radic Biol Med 44 (2008), 1314-1322.
28. E. Malle, G. Marsche, J. Arnhold and M.J. Davies, Modification of low-density lipoprotein by myeroperoxidase-derived oxidants and reagent hypochlorous acid, Biochim Biophys Acta 1761 (2006), 392-415.
29. P. Manini, L. Capelli, S. Reale, M. Arzillo, O. Crescenzi, A. Napolitano, V. Barone and M. d'Ischia, Chemistry of nitrated lipids: remarkable instability of 9-nitrolinoleic acid in neutral aqueous medium and a novel nitronitrate ester production by concurrent autoxidation/nitric oxide-release pathways, J Org Chem 73 (2008), 7517-7525.
30. L.J. Marnett, Oxy radicals, lipid peroxidation and DNA damage, Toxicol 181-182 (2002), 219-222. (Pubitemid 36015702)
31. E.A. Meagher and G.A. FitzGerald, Indices of lipid peroxidation in vivo: strengths and limitations, Free Radic Biol Med 28 (2000), 1745-1750. (Pubitemid 30628661)
32. G.L. Milne, H. Yin and J.D. Morrow, Human biochemistry of the isoprostane pathway, J Biol Chme 283 (2008), 15533-15537.
33. E.S. Misoek, B. McLaughlin and J.D. Morrow, Electophilic cyclopentenone isoprostanes in neurodegeneration, J Mol Neurosci 33 (2007), 80-86.
34. T. Miyazawa, K. Yasuda, K. Fujimoto and T. Kaneda, Chemiluminescence-high performance liquid chromatography of phosphatidylcholine hydroperoxide in human plasma, Basic Life Sci 49 (1988), 191-194.
35. T.J. Mocatta, A.P. Pilbrow, V.A. Cameron, R. Senthilmohan, C.M. Frampton, A.M. Richards and C.C. Winterbourn, Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction, J Am Coll Cardiol 49 (2007), 1993-2000. (Pubitemid 46734639)
36. T.J. Montine, J. Quinn, J. Kaye and J.D. Morrow, F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease, J Mol Neurosci 33 (2007), 114-119. (Pubitemid 47574948)
37. J.D. Morrow, K.E. Hill, R.F. Burk, T.M. Nammour, K.F. Badr and L.J. Roberts 2nd, A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism, Proc Natl Acad Sci USA 87 (1990), 9383-9387.
38. U. Nair, H. Bartsch and J. Nair, Lipid peroxidation-induced DNA damage in cancer-prone inflammatory diseases: a review of published adduct types and levels in humans, Free Radic Biol Med 43 (2007), 1109-1120.
39. K. Nakagawa, M. Ninomiya, T. Okubo, N. Aoi, L.R. Juneja, M. Kim, K. Yamanaka and T. Miyazawa, Tea catechin supplementation increases antioxidant capacity and prevents phospholipids hydroperoxidation in plasma of humans, J Agirc Food chem 47 (1999), 3967-3973.
40. E. Niki,Y.Yoshida, Y. Saito and N. Noguchi, Lipid peroxidation: mechanisms, inhibition, and biological effects, Biochem Biophys Res Commun 338 (2005), 668-676. (Pubitemid 41540614)
41. N. Noguchi and E. Niki, Dynamics of free radical formation from the reaction of peroxides with haemproteins as studied by stopped-flow chemiluminescence, Free Radic Res 23 (1995), 329-338.
42. N. Noguchi, N. Nakada, Y. Itoh, A. Watanabe and E. Niki. Formation of active oxygen species and lipid peroxidation induced by hypochlorite, Arch Biochem Biophys 397 (2002), 440-447. (Pubitemid 34852315)
43. N. Noguchi, R. Numano, H. Kaneda and E. Niki, Oxidation of lipids in low density lipoprotein particles, Free Radic Res 29 (1998), 43-52. (Pubitemid 28451186)
44. Y. Ogawa, Y. Saito, K. Nishio, Y. Yoshida, H. Ashida and E. Niki, Gamma-tocopheryl quinine, not alpha-tocopheryl quinine, induces adaptive response through up-regulation of cellular glutathione and cysteine availability via activation of ATF4, Free Radic Res 42 (2008), 673-687.
45. M. Orfanopoulos and S.S. Foote, The ene reaction of singlet oxygen with olefins, Free Radic Res Commun 2 (1987), 321-326.
46. O.M. Panasenko, The mechanism of the hypochlorite induced lipid peroxidation, BioFactors 6 (1997), 181-190. (Pubitemid 27487823)
47. S. Parthasarathy, D. Litvinov, K. Selvarajan and M. Garelnabi, Lipid peroxidation and decomposition - Conflicting roles in plaque vulnerability and stability, Biochim Biophys Acta 1782 (2008), 221-231.
48. G. Peiro, A. Alary, J.P. Cravedi, E. Tathahao, J.P. Steghens and F. Gueraud, Dihydroxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid Peroxidation, BioFactors 24 (2005), 89-96.
49. L.J. Roberts, 2nd. J.P. Fessel and S.S. Davies, The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation, Brain Pathol 15 (2005), 143-148.
50. H. Rubbo and R. Radi, Protein and lipid nitration: Role in redox signaling and injury, Biochim Biophys Acta (2008).
51. L.M. Sayre, G. Perry and M.T. Smith, Oxidative stress and neurotoxicity, Chem Res Toxicol 21 (2008), 172-188.
52. C. Schneider, D.A. Pratt, N.A. Porter and A.R. Brash, Control of oxygenation in lipoxygenase and cyclooxygenase catalysis, Chem Biol 14 (2007), 473-488.
53. C.M. Spickett, A. Jerlich, O.M. Panasenko, J. Arnhold, A.R. Pitt, T. Stelmaszynska and J. Schaur, The reactions of hypochlorous acid, the reactive oxygen species produced by myeloperoxidase, with lipids, Acta Biochim Pol 47 (2000), 889-899.
54. D. Steinberg, The LDL modification hypothesis of atherogenesis: an update, J Lipid Res (2008), in press, PMID: 19011257.
55. D. Steinberg, The LDL modification hypothesis of atherogenesis: an update, J Lipid Res, In press, PMID: 19011257.
56. G. Takebe, J. Yarimizu, Y. Saito, T. Hayashi, H. Nakamura, J. Yodoi, S. Nagasawa and K. Takahashi, A comparative study on the hydroperoxide and thiol specificity of the glutathione peroxidase family and selenoprotein P, J Biol Chem 277 (2002), 41254-41258.
57. K. Uchida, Histidine and lysine as targets of oxidative modification, Amino Acids 25 (2003), 249-257.
58. F. Ursini, M. Maiorino, R. Brigelius-Flohe, K.D. Aumann, A. Roveri, D. Schonmburg and L. Flohe, Diveristy of glutathione peroxidases, Methods Enzymol 252 (1995), 38-53.
59. A. Vejux, L. Malvitte and G. Lizard, Side effects of oxysterols: cytotoxicity, oxidation, inflammation, and phospholipidosis, Braz J Med Biol Res 41 (2008), 545-556.
60. R.Wilson, K. Lyall, L. Smith, C.E. Femie and R.A. Rimersma, Dietary fatty acids are absorbed in humans: implications for the measurement of oxidative stress in vivo, Free Radic Biol Med 32 (2002), 162-168.
61. Y. Yamamoto, M.H. Brodsy, J.C. Baker and B.N. Ames, Detection and characterization of lipid hydroperoixdes at picomole levels by high-performance liquid chromatography, Anal Biochem 160 (1987), 7-13. (Pubitemid 17020592)
62. H. Yin and N.A. Porter, New insights regarding the autoxidation of polyunsaturated fatty acids, Antioxid Redox Signal 7 (2005), 170-184.
63. H. Yin, New techniques to detect oxidative stress markers: mass spectrometry-based methods to detect isoprostanes as the gold standard for oxidative stress in viov, BioFactors, this issue.
64. Y. Yoshida and E. Niki, Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol, BioFactors 27 (2006), 195-202. (Pubitemid 44434943)
65. Y. Yoshida, M. Hayakawa, Y. Habuchi, N. Itoh and E. Niki, Evaluation of lipophilic antioxidant efficacy in vivo by the biomarkers hydroxyoctadecadienoic acid and isoprostane, Lipids 42 (2007), 463-472.
66. Y. Yoshida, Y. Saito, M. Hayakawa, Y. Habuchi, N.Y. Imai, Y. Sawai and E. Niki, Levels of lipid peroxidation in human plasma and erythrocytes: comparison between fatty acids and cholesterol, Lipids 42 (2007), 439-449.